Welch & Forbes LLC Novo Nordisk A S Transaction History

Welch & Forbes LLC

$7.73 Billion
Q3 2024

A detailed history of Welch & Forbes LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Welch & Forbes LLC holds 21,426 shares of NVO stock, worth $1.82 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

21,426

Previous 21,396 0.14%

Holding current value

$1.82 Million

Previous $3.05 Million 16.47%

% of portfolio

0.03%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$119.07 - $145.42 $3,572 - $4,362	30 Added 0.14%	21,426 $2.55 Million
Q2 2024 Aug 01, 2024	SELL	$122.71 - $146.91 $10,921 - $13,074	-89 Reduced 0.41%	21,396 $3.05 Million
Q1 2024 May 02, 2024	SELL	$102.11 - $135.92 $11,538 - $15,358	-113 Reduced 0.52%	21,485 $2.76 Million
Q4 2023 Feb 06, 2024	SELL	$87.78 - $105.45 $8,778 - $10,545	-100 Reduced 0.46%	21,598 $2.23 Million
Q3 2023 Nov 02, 2023	BUY	$90.94 - $199.54 $998,339 - $2.19 Million	10,978 Added 102.41%	21,698 $1.97 Million
Q2 2023 Jul 28, 2023	BUY	$155.98 - $172.65 $258,926 - $286,599	1,660 Added 18.32%	10,720 $1.73 Million
Q1 2023 Apr 14, 2023	BUY	$132.34 - $159.14 $1,985 - $2,387	15 Added 0.17%	9,060 $1.44 Million
Q4 2022 Feb 02, 2023	SELL	$102.55 - $135.33 $51,275 - $67,665	-500 Reduced 5.24%	9,045 $1.22 Million
Q3 2022 Oct 28, 2022	BUY	$95.28 - $116.93 $47,640 - $58,465	500 Added 5.53%	9,545 $951,000
Q1 2022 Apr 25, 2022	SELL	$93.1 - $112.54 $837 - $1,012	-9 Reduced 0.1%	9,045 $1.01 Million
Q4 2021 Jan 19, 2022	SELL	$95.88 - $117.08 $16,395 - $20,020	-171 Reduced 1.85%	9,054 $1.01 Million
Q3 2021 Oct 13, 2021	BUY	$84.42 - $106.62 $84,420 - $106,620	1,000 Added 12.16%	9,225 $885,000
Q3 2020 Oct 23, 2020	SELL	$63.69 - $70.22 $25,476 - $28,088	-400 Reduced 4.64%	8,225 $571,000
Q2 2020 Jul 15, 2020	SELL	$58.54 - $67.94 $31,611 - $36,687	-540 Reduced 5.89%	8,625 $564,000
Q4 2019 Jan 17, 2020	SELL	$49.86 - $58.26 $1,994 - $2,330	-40 Reduced 0.43%	9,165 $530,000
Q2 2019 Jul 12, 2019	BUY	$46.79 - $52.47 $3,743 - $4,197	80 Added 0.88%	9,205 $470,000
Q4 2018 Feb 05, 2019	SELL	$41.54 - $47.25 $6,231 - $7,087	-150 Reduced 1.62%	9,125 $420,000
Q3 2018 Oct 17, 2018	SELL	$46.76 - $51.24 $1,870 - $2,049	-40 Reduced 0.43%	9,275 $437,000
Q2 2018 Jul 16, 2018	SELL	$44.29 - $50.42 $7,086 - $8,067	-160 Reduced 1.69%	9,315 $430,000
Q1 2018 Apr 12, 2018	BUY	$48.49 - $58.14 $459,442 - $550,876	9,475 New	9,475 $467,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Welch & Forbes LLC, based on Form 13F filings with the SEC.

News

Stay updated on Welch & Forbes LLC with notifications on news.

Account